Amarin reported $973.71M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
DBV Technologies DBVT:US 117.58M 29.14M
Abbvie ABBV:US $ 143211M 3318M
Aerie Pharmaceuticals AERI:US $ 395.55M 35.84M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Amarin AMRN:US $ 973.71M 94.36M
AstraZeneca AZN:LN 100273M 5090M
Biocryst Pharmaceuticals BCRX:US $ 527.72M 60.43M
Epizyme EPZM:US $ 312.19M 23.19M
Esperion Therapeutics ESPR:US $ 342.85M 38.74M
GlaxoSmithKline GSK:LN 89689M 10586M
Halozyme Therapeutics HALO:US $ 1162.25M 57.82M
Heron Therapeutics HRTX:US $ 273.72M 31.98M
Intercept Pharmaceuticals ICPT:US $ 503.36M 23.67M
JAZZ PHA JAZZ:US $ 11768.92M 529.72M
Nektar Therapeutics NKTR:US $ 1024.12M 93.07M
Novartis NOVN:VX SF 125218M 6577M
Teva Pharmaceutical Industries TEVA:US $ 47059M 607M